Four years after the first whistle blow of microcephaly associated with Zika virus infections and science is still scratching its metaphoric head trying to figure out how zika virus works. Though reports of outbreaks have receded since the epidemic of the Americas in 2014-2016, the threat it poses on pregnant women -being an endemic virus- remains severely high.
One of the challenges for the consortium has been to identify specific and sensitive zika antibody assays for use in its prospective and retrospective studies. Recently the Diagnostic Development Laboratory of the BNITM (Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany) has developed the BLACKBOX® ZIKV IgG and IgM ELISA Kits
Translatable animal infection models ZIKV infection that recapitulate human disease can assist in unraveling the unique effects of ZIKV on the human reproductive tract and the developing fetus. Mice have been used as one of the most accessible models of ZIKV
The ZIKAction prospective cohort study of pregnant women and their Infants to investigate vertical transmission (VT) of ZIKV, CHIKV and DENV started enrolling in Jamaica in June 2017. This study saw 606 pregnant women enrolled in Greater Kingston, Jamaica, as of April 14, 2019
We extend our hearty congratulations to Professor Celia Christie-Samuels, who on the National Heroes Day in Jamaica was conferred with the Jamaican national honour of Order of Distinction in the rank of Commander (CD).
Earlier this month the third annual ZIKAction Consortium meeting took place in Brazil. On 3-5th November around 40 scientists and health professionals gathered in Rio de Janeiro to discuss the ongoing project studies, review the progress already made and to deliberate on the challenges faced on the path towards a successful implementation of the project.